Conventional Interferon Alpha Therapy of Chronic Hepatitis C in Patients with End Stage Renal Disease, Six versus Twelve Months? A Meta-Analysis

Author(s):
Seyed Moayed AlavianSeyed Moayed AlavianSeyed Moayed Alavian ORCID1,*, Seyed Vahid TabatabaeiSeyed Vahid Tabatabaei2
1Research Center for Gastroenterology and Liver Disease,Baqiyatallah Research Center for Gastroenterology and Liver Diseases, [email protected], IR-Iran
2Research Center for Gastroenterology and Liver Disease,Baqiyatallah University of Medical Sciences, IR-Iran

Nephro-Urology Monthly:Vol. 1, issue 1; 4-13
Published online:Jun 30, 2009
Article type:Review Article
How to Cite:Alavian S, Tabatabaei S. Conventional Interferon Alpha Therapy of Chronic Hepatitis C in Patients with End Stage Renal Disease, Six versus Twelve Months? A Meta-Analysis. Nephro-Urol Mon. 2009;1(1):. doi:

Abstract

Full Text

Full text is available in PDF

Similar Articles

31
Jan
2011

Ribavirin Combination Therapy of Chronic Hepatitis C Patients with End Stage Renal Disease: Review of Evidences on Efficacy and Safety

Seyed Moayed Alavian,
Vahid Tabatabaee,
Kamran Bagheri Lankarani

Alavian S, Tabatabaee V, Lankarani K. Ribavirin Combination Therapy of Chronic Hepatitis C Patients with End Stage Renal Disease: Review of Evidences on Efficacy and Safety. Nephro-Urol Mon. 2011;3(1):. doi:

18
Apr
2021
Nephro-Urol Mon

The Efficacy and Safety of Sofosbuvir/Daclatasvir Fixed-Dose Combination in Iranian Hemodialysis Patients with Hepatitis C Virus Infection

Kasra Ghanaat,
Heidar Sharafi,
Seyed Moayed Alavian

Ghanaat K, Sharafi H, Alavian SM. The Efficacy and Safety of Sofosbuvir/Daclatasvir Fixed-Dose Combination in Iranian Hemodialysis Patients with Hepatitis C Virus Infection. Nephro-Urol Mon. 2021;13(2):e114049. doi: https://doi.org/10.5812/numonthly.114049

12
Nov
2016

Successful Treatment of Acute Hepatitis C Virus (HCV) Infection with Interferon-Free Regimen in a Renal Transplant Patient: The First Case Report

Nawfal R Hussein,
Zana Sidiq Mohammed Saleem

Hussein NR, Saleem ZSM. Successful Treatment of Acute Hepatitis C Virus (HCV) Infection with Interferon-Free Regimen in a Renal Transplant Patient: The First Case Report. Int J Infect. 2017;4(4):e43268. doi: https://doi.org/10.17795/iji-43268

1
Jan
2015

Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

Heidar Sharafi,
Seyed Moayed Alavian,
Maryam Keshvari

Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1):e24955. doi: https://doi.org/10.5812/hepatmon.24955

1
Jan
2006

Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

SM Alavian,
A Kabir,
B Hajarizadeh,
M Nayebpour,
T Dorodi,
FE Baralle

Alavian S, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, et al. Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study. Shiraz E-Med J. 2006;7(1):20390. doi:

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCCÂ